- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT07565519
Effects of a Multicomponent Exercise Program in Older Adults Undergoing Cancer Treatment: A Randomized Controlled Trial
Effects of a Multicomponent Exercise Program on Functional Capacity, Neuromuscular Parameters, Quality of Life, and Disease-Related Symptoms in Older Adults Undergoing Cancer Treatment: A Randomized, Controlled Clinical Trial
This study aims to understand how a home-based exercise program can help improve strength, mobility, and quality of life in older adults receiving cancer treatment.
Participants will be randomly divided into two groups:
One group will follow a one-year multicomponent exercise program based on the ViviFrail model, done safely at home.
The other group will continue with usual care.
We will include men and women aged 60 or older treated at Hospital Conceição in Porto Alegre. Assessments will take place at the beginning and after 12, 24, and 48 weeks.
We will measure walking speed, balance, muscle strength, and ask about quality of life, symptoms, and daily activity.
The goal is to see whether home-based exercise can help older adults with cancer stay stronger, more independent, and feel better during treatment.
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Szczegółowy opis
Typ studiów
Zapisy (Szacowany)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Kontakt w sprawie studiów
- Nazwa: Eduardo L Cadore, PhD
- Numer telefonu: +555191193651
- E-mail: edcadore@yahoo.com.br
Lokalizacje studiów
-
-
-
Porto Alegre, Brazylia, 91350-200
- Rekrutacyjny
- Hospital Conceição
-
Kontakt:
- Eduarda Blanco Rambo, Me
- Numer telefonu: 5551999079773
- E-mail: eduardarambo@gmail.com
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brazylia, 90690-200
- Jeszcze nie rekrutacja
- Escola de Educação Física Fisioterapia e Dança - UFRGS
-
Kontakt:
- Eduardo L Cadore, PhD
- Numer telefonu: +555191193651
- E-mail: edcadore@yahoo.com.br
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
- Dorosły
- Starszy dorosły
Akceptuje zdrowych ochotników
Opis
Inclusion Criteria: Men and women aged 60 years or older who are undergoing cancer treatment at Hospital Conceição in Porto Alegre, who have the cognitive ability to understand the exercises, are able to walk (even with assistance), and have medical clearance to participate in physical exercise will be included in the study.
-
Exclusion Criteria: Participants who miss more than two assessments will be excluded.
-
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Pojedynczy
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Eksperymentalny: Multicomponent Training
Multicomponent exercise
|
Participants randomized to the intervention group will receive educational material about exercising during cancer treatment.
In addition, they will receive a physical exercise passport based on the ViviFrail program (A, B, C, or D) according to their baseline assessment.
The passport includes instructions and illustrations of each exercise, as well as details on the number of sets and repetitions, required equipment, and a training log.
Furthermore, participants in the intervention group will have access to online materials, including videos demonstrating each exercise, and will attend a pre-scheduled in-person session at Hospital Conceição in Porto Alegre to address any questions.
|
|
Brak interwencji: Control
Patients randomized to the control group will receive general health guidance and instructions to continue with their usual care.
To monitor participants in both groups over time, monthly contacts will be made via phone or messaging app.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Gait ability
Ramy czasowe: From enrollment and at 4, 12, 24 and 48 weeks
|
Timed Up and Go test and the 6-meter gait speed test, following the recommendations of Izquierdo (2019)
|
From enrollment and at 4, 12, 24 and 48 weeks
|
|
Hand grip strength
Ramy czasowe: From enrollment and at 4, 12, 24 and 48 weeks
|
Will be measured using a Jamar Hydraulic Hand Dynamometer, following the guidelines of the American Society of Hand Therapists (MacDermid et al., 2015).
|
From enrollment and at 4, 12, 24 and 48 weeks
|
|
SPPB Battery
Ramy czasowe: From enrollment and at 4, 12, 24 and 48 weeks
|
SPPB tests: the five-times sit-to-stand test from a standard chair, 4-meter gait speed test, and balance tests in bipodal, semi-tandem, and tandem positions.
(Izquierdo, 2019)
|
From enrollment and at 4, 12, 24 and 48 weeks
|
|
Peak power on seat to standing movement
Ramy czasowe: From enrollment and at 4, 12, 24 and 48 weeks
|
using a linear displacement transducer (encoder) during the three-times sit-to-stand test from a standard chair.
The participant will start seated, with their hands resting on their knees, and the encoder will be attached to the right wrist using a Velcro strap.
At the command "go," the participant will be instructed to stand up from the chair as quickly as possible and sit back down, repeating the movement three times.
|
From enrollment and at 4, 12, 24 and 48 weeks
|
|
number of hospitalizations
Ramy czasowe: From enrollment and at the end of the study, in 48 weeks
|
Standardized questionnaire
|
From enrollment and at the end of the study, in 48 weeks
|
|
Treatment toxicity
Ramy czasowe: From enrollment and at the end of the study, in 48 weeks
|
NCI-PRO-CTCAE ITEMS - Portuguese for Brazil, following the recommendations of Pires et al. (2022).
|
From enrollment and at the end of the study, in 48 weeks
|
|
Mortality rate
Ramy czasowe: From enrollment and at the end of the study, in 48 weeks
|
Standardized questionnaire
|
From enrollment and at the end of the study, in 48 weeks
|
|
Number of falls
Ramy czasowe: From enrollment and at 4, 12, 24 and 48 weeks
|
Standardized questionnaire
|
From enrollment and at 4, 12, 24 and 48 weeks
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Physical activity level
Ramy czasowe: From enrollment and at the end of the study, in 48 weeks
|
Physical activity level will be assessed using the Baecke Physical Activity Questionnaire (Simões, 2009), which refers to the 12 months prior to the study and is divided into questions related to daily living activities, sports activities, and leisure activities.
Participants will be classified as low physical activity (≤ 9.11 points), moderately active (9.12 to 16.17 points), or highly active (≥ 16.18 points).
|
From enrollment and at the end of the study, in 48 weeks
|
|
Vastus lateralis muscle thickness
Ramy czasowe: From enrollment and at 4, 12, 24 and 48 weeks
|
Muscle thickness will be assessed using ultrasonography (Nemio XG, Toshiba, Japan) of the vastus lateralis of the participants' right leg, following the recommendations of Pinto et al. (2015).
Three images of the vastus lateralis will be collected at 30% of the distance from the lateral femoral epicondyle to the greater trochanter, along the patella.
A tracing map on acetate will be produced to ensure greater precision in repeated measurements.
|
From enrollment and at 4, 12, 24 and 48 weeks
|
|
Vastus intermedius muscle thickness
Ramy czasowe: From enrollment and at 4, 12, 24 and 48 weeks
|
Muscle thickness will be assessed using ultrasonography (Nemio XG, Toshiba, Japan) of the vastus intermedius of the participants' right leg, following the recommendations of Pinto et al. (2015).
Three images of the vastus intermedius will be collected at 50% of the distance from the lateral femoral epicondyle to the greater trochanter, along the midline of the patella.
A tracing map on acetate will be produced to ensure greater precision in repeated measurements.
|
From enrollment and at 4, 12, 24 and 48 weeks
|
|
Rectus femoralis muscle thickness
Ramy czasowe: From enrollment and at 4, 12, 24 and 48 weeks
|
Muscle thickness will be assessed using ultrasonography (Nemio XG, Toshiba, Japan) of the rectus femoralis of the participants' right leg, following the recommendations of Pinto et al. (2015).
Three images of the vastus intermedius will be collected at 50% of the distance from the lateral femoral epicondyle to the greater trochanter, along the midline of the patella.
A tracing map on acetate will be produced to ensure greater precision in repeated measurements.
|
From enrollment and at 4, 12, 24 and 48 weeks
|
|
Quality of Life Questionnarie
Ramy czasowe: From enrollment and at 4, 12, 24 and 48 weeks
|
Will be assessed using the Nottingham Health Profile (NHP), which contains 38 items related to overall quality of life and produces a score ranging from 0 (best quality of life) to 38 (worst quality of life) (Teixeira-Salmela et al., 2004).
|
From enrollment and at 4, 12, 24 and 48 weeks
|
|
Fatigue related symptons
Ramy czasowe: From enrollment and at 4, 12, 24 and 48 weeks
|
Brief Fatigue Inventory for fatigue assessment (Mendoza et al., 1999)
|
From enrollment and at 4, 12, 24 and 48 weeks
|
|
Sleep quality
Ramy czasowe: From enrollment and at 4, 12, 24 and 48 weeks
|
Pittsburgh Sleep Quality Index - BR for sleep quality assessment (Buysse et al., 1989)
|
From enrollment and at 4, 12, 24 and 48 weeks
|
|
Disease prognosis
Ramy czasowe: From enrollment and at 4, 12, 24 and 48 weeks
|
Karnofsky Performance Scale Index for disease prognosis (Schag et al., 1984)
|
From enrollment and at 4, 12, 24 and 48 weeks
|
Inne miary wyników
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Sociodemographic characteristics
Ramy czasowe: At the enrollment
|
Standardized questionnaire
|
At the enrollment
|
|
Comorbidities
Ramy czasowe: At the enrollment
|
Standardized questionnaire
|
At the enrollment
|
|
Stage of the tumor
Ramy czasowe: At the enrollment
|
Standardized questionnaire
|
At the enrollment
|
|
Type of tumor
Ramy czasowe: At the enrollment
|
Standardized questionnaire
|
At the enrollment
|
|
Adherence to the exercise program
Ramy czasowe: After 4, 12, 24 and 48 weeks of intervention
|
Exercise adherence will be assessed through monitoring of training logs.
|
After 4, 12, 24 and 48 weeks of intervention
|
|
Total body mass
Ramy czasowe: From enrollment and at the end of the study, in 48 weeks
|
Will be measured using a digital scale
|
From enrollment and at the end of the study, in 48 weeks
|
|
Body height
Ramy czasowe: From enrollment and at the end of the study, at 48 weeks
|
Will be measured using a measuring tape with 1 mm resolution.
|
From enrollment and at the end of the study, at 48 weeks
|
|
Waist circunference
Ramy czasowe: From enrollment and at the end of the study, at 48 weeks
|
Will be measured using a measuring tape with 1 mm resolution.
|
From enrollment and at the end of the study, at 48 weeks
|
|
Nutritional assessment
Ramy czasowe: From enrollment and at the end of the study, at 48 weeks
|
Nutritional status will be evaluated using a three-day dietary recall.
|
From enrollment and at the end of the study, at 48 weeks
|
Współpracownicy i badacze
Śledczy
- Główny śledczy: Eduardo L Cadore, PhD, Federal University of Rio Grande do Sul
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Szacowany)
Ukończenie studiów (Szacowany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- URioGrandeCancer
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Opis planu IPD
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .